INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 174 filers reported holding INOVIO PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.29 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $116 | -12.8% | 300 | 0.0% | 0.00% | – |
| Q2 2023 | $133 | -45.9% | 300 | 0.0% | 0.00% | – |
| Q1 2023 | $246 | -99.8% | 300 | -99.7% | 0.00% | -100.0% |
| Q4 2022 | $156,468 | -9.6% | 100,300 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $173,000 | 0.0% | 100,300 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $173,000 | -51.9% | 100,300 | 0.0% | 0.00% | -50.0% |
| Q1 2022 | $360,000 | -36.1% | 100,300 | -11.2% | 0.00% | -20.0% |
| Q4 2021 | $563,000 | -30.4% | 113,000 | 0.0% | 0.01% | -28.6% |
| Q3 2021 | $809,000 | +373.1% | 113,000 | +510.8% | 0.01% | +600.0% |
| Q2 2021 | $171,000 | 0.0% | 18,500 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $171,000 | +48.7% | 18,500 | +42.3% | 0.00% | 0.0% |
| Q4 2020 | $115,000 | +88.5% | 13,000 | +141.0% | 0.00% | – |
| Q3 2020 | $61,000 | -84.5% | 5,394 | -63.1% | 0.00% | -100.0% |
| Q2 2020 | $393,000 | +222.1% | 14,600 | -11.0% | 0.00% | +100.0% |
| Q1 2020 | $122,000 | +103.3% | 16,400 | -10.9% | 0.00% | +100.0% |
| Q4 2019 | $60,000 | +328.6% | 18,400 | +155.6% | 0.00% | – |
| Q3 2019 | $14,000 | -85.9% | 7,200 | -78.8% | 0.00% | -100.0% |
| Q2 2019 | $99,000 | -21.4% | 34,000 | 0.0% | 0.00% | -50.0% |
| Q1 2019 | $126,000 | – | 34,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON ASSOCIATES LP | 784,679 | $643,437 | 0.10% |
| Green Alpha Advisors, LLC | 146,300 | $119,966 | 0.08% |
| Virtus ETF Advisers LLC | 54,106 | $44,367 | 0.02% |
| Cedar Brook Financial Partners, LLC | 104,881 | $86,002 | 0.02% |
| PROFUND ADVISORS LLC | 418,749 | $343,374 | 0.02% |
| Arlington Capital Management, Inc. | 27,735 | $22,743 | 0.02% |
| Hennion & Walsh Asset Management, Inc. | 382,158 | $313 | 0.02% |
| Rafferty Asset Management, LLC | 2,647,927 | $2,171,300 | 0.02% |
| Brainard Capital Management LLC | 16,666 | $13,666 | 0.01% |
| Beck Bode, LLC | 41,218 | $33,799 | 0.01% |